158 related articles for article (PubMed ID: 34285619)
1. Eliciting Health State Utilities for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency: A Vignette Study in France.
Smith AB; Hanbury A; Beitia Ortiz de Zarate I; Hammes F; de Pouvourville G; Buesch K
Patient Relat Outcome Meas; 2021; 12():237-246. PubMed ID: 34285619
[TBL] [Abstract][Full Text] [Related]
2. Eliciting health state utilities for Aromatic L-amino Acid Decarboxylase (AADC) deficiency: a UK vignette study.
Smith AB; Hanbury A; Buesch K
J Patient Rep Outcomes; 2021 Dec; 5(1):130. PubMed ID: 34897562
[TBL] [Abstract][Full Text] [Related]
3. A Discrete Choice Experiment to Derive Health Utilities for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency in France.
Smith AB; Hanbury A; Whitty JA; Beitia Ortiz de Zarate I; Hammes F; de Pouvourville G; Buesch K
Patient Relat Outcome Meas; 2022; 13():21-30. PubMed ID: 35115856
[TBL] [Abstract][Full Text] [Related]
4. A Discrete Choice Experiment to Derive Health Utilities for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency.
Smith AB; Hanbury A; Whitty JA; Buesch K
Patient Relat Outcome Meas; 2021; 12():97-106. PubMed ID: 34012310
[TBL] [Abstract][Full Text] [Related]
5. Deriving Vignettes for the Rare Disease AADC Deficiency Using Parent, Caregiver and Clinician Interviews to Evaluate the Impact on Health-Related Quality of Life.
Hanbury A; Smith AB; Buesch K
Patient Relat Outcome Meas; 2021; 12():1-12. PubMed ID: 33447119
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Outcomes of Eladocagene Exuparvovec Compared with Standard of Care in Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency: A Modelling Study.
Simons CL; Hwu WL; Zhang R; Simons MJHG; Bergkvist M; Bennison C
Adv Ther; 2023 Dec; 40(12):5399-5414. PubMed ID: 37803205
[TBL] [Abstract][Full Text] [Related]
7. Time Trade-Off Utilities for Hereditary Angioedema Health and Caregiver States.
Lo SH; Lloyd A; Elkhalifa S; Sisic Z; van Nooten FE
Pharmacoecon Open; 2022 Mar; 6(2):231-239. PubMed ID: 34532843
[TBL] [Abstract][Full Text] [Related]
8. Symptoms and impacts of aromatic L-amino acid decarboxylase (AADC) deficiency among individuals with different levels of motor function.
Williams K; Skrobanski H; Buesch K; Acaster S
Orphanet J Rare Dis; 2022 Mar; 17(1):128. PubMed ID: 35313922
[TBL] [Abstract][Full Text] [Related]
9. Eladocagene Exuparvovec: First Approval.
Keam SJ
Drugs; 2022 Sep; 82(13):1427-1432. PubMed ID: 36103022
[TBL] [Abstract][Full Text] [Related]
10. Estimation of Health State Utility Values in Fabry Disease Using Vignette Development and Valuation.
Hughes D; Lenny A; Shah K; Longworth L; Devercelli G; Ayodele O
J Health Econ Outcomes Res; 2023; 10(1):80-88. PubMed ID: 37064293
[No Abstract] [Full Text] [Related]
11. Impact of caregiver and parenting status on time trade-off and standard gamble utility scores for health state descriptions.
Matza LS; Boye KS; Feeny DH; Johnston JA; Bowman L; Jordan JB
Health Qual Life Outcomes; 2014 Apr; 12():48. PubMed ID: 24716709
[TBL] [Abstract][Full Text] [Related]
12. Quality of Life with Late-Onset Pompe Disease: Qualitative Interviews and General Public Utility Estimation in the United Kingdom.
Hubig L; Sussex AK; MacCulloch A; Hughes D; Graham R; Morris L; Raza S; Lloyd AJ; Sowinski A; Gallop K
J Health Econ Outcomes Res; 2023; 10(1):41-50. PubMed ID: 36883056
[No Abstract] [Full Text] [Related]
13. Patient-Proxy and Societal Perspectives of Quality-of-Life Utilities in Children With Cleft Lip and Palate Managed With Surgical Repair vs No Repair in Ethiopia.
Chung KY; Gebretekle GB; Howard A; Pullenayegum E; Eshete M; Forrest CR; Sander B
JAMA Netw Open; 2022 Jul; 5(7):e2220900. PubMed ID: 35834253
[TBL] [Abstract][Full Text] [Related]
14. A structured review of health utility measures and elicitation in advanced/metastatic breast cancer.
Hao Y; Wolfram V; Cook J
Clinicoecon Outcomes Res; 2016; 8():293-303. PubMed ID: 27382319
[TBL] [Abstract][Full Text] [Related]
15. Vignette-Based Utilities: Usefulness, Limitations, and Methodological Recommendations.
Matza LS; Stewart KD; Lloyd AJ; Rowen D; Brazier JE
Value Health; 2021 Jun; 24(6):812-821. PubMed ID: 34119079
[TBL] [Abstract][Full Text] [Related]
16. Detection of 3-O-methyldopa in dried blood spots for neonatal diagnosis of aromatic L-amino-acid decarboxylase deficiency: The northeastern Italian experience.
Burlina A; Giuliani A; Polo G; Gueraldi D; Gragnaniello V; Cazzorla C; Opladen T; Hoffmann G; Blau N; Burlina AP
Mol Genet Metab; 2021 May; 133(1):56-62. PubMed ID: 33744095
[TBL] [Abstract][Full Text] [Related]
17. A review of health utilities across conditions common in paediatric and adult populations.
Tarride JE; Burke N; Bischof M; Hopkins RB; Goeree L; Campbell K; Xie F; O'Reilly D; Goeree R
Health Qual Life Outcomes; 2010 Jan; 8():12. PubMed ID: 20105304
[TBL] [Abstract][Full Text] [Related]
18. Health state utilities associated with hyperphagia: Data for use in cost-utility models.
Howell TA; Matza LS; Mallya UG; Goldstone AP; Butsch WS; Lazarus E
Obes Sci Pract; 2023 Aug; 9(4):376-382. PubMed ID: 37546284
[TBL] [Abstract][Full Text] [Related]
19. Estimating health state utilities associated with a rare disease: familial chylomicronemia syndrome (FCS).
Matza LS; Phillips GA; Howell TA; Ciffone N; Ahmad Z
J Med Econ; 2020 Sep; 23(9):978-984. PubMed ID: 32479143
[No Abstract] [Full Text] [Related]
20. Semi-quantitative detection of a vanillactic acid/vanillylmandelic acid ratio in urine is a reliable diagnostic marker for aromatic L-amino acid decarboxylase deficiency.
Brennenstuhl H; Garbade SF; Okun JG; Feyh P; Hoffmann GF; Langhans CD; Opladen T
Mol Genet Metab; 2020; 131(1-2):163-170. PubMed ID: 32675002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
